Changle Ke
Impact in
-
- MicroRNA in disease regulation
-
- Mesenchymal stem cell research
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 1
-
- Liver Disease Diagnosis and Treatment 1
- Co-authors
- Yinchuan Xu (2 shared papers)Changchen Xiao (3 shared papers)Xianpeng Wu (3 shared papers)Jinghai Chen (2 shared papers)Xinyang Hu (2 shared papers)Zhiwei Zhong (1 shared paper)Jianan Wang (1 shared paper)Shuhan Zhong (1 shared paper)
- Journals
- Circulation Research (1 paper)Journal of Molecular and Cellular Cardiology (1 paper)Hepatology (1 paper)Journal of Lipid Research (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Changle Ke
4 papers receiving 263 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 88
- Genetics 28
- Molecular Biology 176
- Cardiology and Cardiovascular Medicine 37
- Epidemiology 48
Countries citing papers authored by Changle Ke
This map shows the geographic impact of Changle Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changle Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changle Ke more than expected).
Fields of papers citing papers by Changle Ke
This network shows the impact of papers produced by Changle Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changle Ke. The network helps show where Changle Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Changle Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 228 | |
| 2 | 2019 | 21 | |
| 3 | 2023 | 14 | |
| 4 | 2025 | 1 |
About Changle Ke
Changle Ke is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology, Endocrinology, Diabetes and Metabolism, Biochemistry and Infectious Diseases, having authored 4 papers that have together received 264 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Diet, Metabolism, and Disease (1 paper), Liver Disease Diagnosis and Treatment (1 paper) and Lipid metabolism and biosynthesis (1 paper). The work is most often cited by research in Cancer Research (88 citations), Genetics (28 citations), Molecular Biology (176 citations), Cardiology and Cardiovascular Medicine (37 citations) and Epidemiology (48 citations). Changle Ke has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yinchuan Xu, Changchen Xiao, Xianpeng Wu, Jinghai Chen, Xinyang Hu, Zhiwei Zhong, Jianan Wang, Shuhan Zhong, Jing Zhao and Dan Zhu. Their work appears in journals such as Circulation Research, Journal of Molecular and Cellular Cardiology, Hepatology and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.